96 related articles for article (PubMed ID: 38501098)
1. Angiogenesis and Fibrogenesis in Chronic Liver Diseases.
Bocca C; Novo E; Miglietta A; Parola M
Cell Mol Gastroenterol Hepatol; 2015 Sep; 1(5):477-488. PubMed ID: 28210697
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease.
Lefere S; Van Steenkiste C; Verhelst X; Van Vlierberghe H; Devisscher L; Geerts A
Cell Mol Life Sci; 2016 Sep; 73(18):3419-31. PubMed ID: 27091156
[TBL] [Abstract][Full Text] [Related]
3. UCHL1-dependent control of Hypoxia-Inducible Factor Transcriptional Activity during Liver Fibrosis.
Collins A; Scott R; Wilson CL; Abbate G; Ecclestone G; Albanese AG; Biddles D; White S; French J; Moir J; Alrawashdeh W; Wilson C; Pandanaboyana S; Hammond JS; Thakkar R; Oakley F; Mann J; Mann D; Kenneth N
Biosci Rep; 2024 May; ():. PubMed ID: 38808772
[TBL] [Abstract][Full Text] [Related]
4. The mechanical mechanism of angiotensin II induced activation of hepatic stellate cells promoting portal hypertension.
Zhang Y; Xing M; Meng F; Zhu L; Huang Q; Ma T; Fang H; Gu X; Huang S; Wu X; Lv G; Guo J; Wu L; Liu X; Chen Z
Eur J Cell Biol; 2024 May; 103(2):151427. PubMed ID: 38820882
[TBL] [Abstract][Full Text] [Related]
5. Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease.
Kimura T; Singh S; Tanaka N; Umemura T
Front Endocrinol (Lausanne); 2021; 12():773432. PubMed ID: 34938271
[TBL] [Abstract][Full Text] [Related]
6. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).
Saeed A; Dullaart RPF; Schreuder TCMA; Blokzijl H; Faber KN
Nutrients; 2017 Dec; 10(1):. PubMed ID: 29286303
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor-2α promotes fibrosis in non-alcoholic fatty liver disease by enhancing glutamine catabolism and inhibiting yes-associated protein phosphorylation in hepatic stellate cells.
Yan R; Cai H; Zhou X; Bao G; Bai Z; Ge RL
Front Endocrinol (Lausanne); 2024; 15():1344971. PubMed ID: 38501098
[TBL] [Abstract][Full Text] [Related]
8. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
[TBL] [Abstract][Full Text] [Related]
9. Oxygen therapy alleviates hepatic steatosis by inhibiting hypoxia-inducible factor-2α.
Yu L; Wang H; Han X; Liu H; Zhu D; Feng W; Wu J; Bi Y
J Endocrinol; 2020 Jul; 246(1):57-67. PubMed ID: 32369776
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation.
Foglia B; Sutti S; Cannito S; Rosso C; Maggiora M; Autelli R; Novo E; Bocca C; Villano G; Ramavath NN; Younes R; Tusa I; Rovida E; Pontisso P; Bugianesi E; Albano E; Parola M
Cell Mol Gastroenterol Hepatol; 2022; 13(2):459-482. PubMed ID: 34655812
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway.
Chen J; Chen J; Fu H; Li Y; Wang L; Luo S; Lu H
Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E710-E722. PubMed ID: 31430204
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor-2 promotes liver fibrosis in non-alcoholic steatohepatitis liver disease via the NF-κB signalling pathway.
Cai H; Bai Z; Ge RL
Biochem Biophys Res Commun; 2021 Feb; 540():67-74. PubMed ID: 33450482
[TBL] [Abstract][Full Text] [Related]
13. Targeting Endothelial HIF2α/ARNT Expression for Ischemic Heart Disease Therapy.
Ullah K; Ai L; Humayun Z; Wu R
Biology (Basel); 2023 Jul; 12(7):. PubMed ID: 37508425
[TBL] [Abstract][Full Text] [Related]
14. Targeting YAP-mediated HSC death susceptibility and senescence for treatment of liver fibrosis.
Du K; Maeso-Díaz R; Oh SH; Wang E; Chen T; Pan C; Xiang K; Dutta RK; Wang XF; Chi JT; Diehl AM
Hepatology; 2023 Jun; 77(6):1998-2015. PubMed ID: 36815382
[TBL] [Abstract][Full Text] [Related]
15. Hif-2α regulates lipid metabolism in alcoholic fatty liver disease through mitophagy.
Wu MF; Zhang GD; Liu TT; Shen JH; Cheng JL; Shen J; Yang TY; Huang C; Zhang L
Cell Biosci; 2022 Dec; 12(1):198. PubMed ID: 36476627
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
